Bayesian Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bayesian Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,986	Closed	-$356K	–	1145
2022 Q4	$356K	Buy	+8,986	New	+$374K	0.05%	441
2020 Q2	–	Sell	-13,267	Closed	-$1.33M	–	843
2020 Q1	$1.33M	Buy	13,267 +1,726	+15%	+$208K	0.29%	78
2019 Q4	$1.36M	Buy	+11,541	New	+$1.14M	0.23%	119
2016 Q4	–	Sell	-4,833	Closed	-$505K	–	730
2016 Q3	$505K	Buy	4,833 +1,620	+50%	+$146K	0.33%	108
2016 Q2	$237K	Buy	+3,213	New	+$218K	0.14%	280

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bayesian Capital Management's NVRO Position: Q1 2023 in Review

Bayesian Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 8,986 shares — an estimated $356K sold.

Bayesian Capital Management first reported a position in NVRO in Q2 2016 and held it in 5 quarters. The position peaked at $1.36M in Q4 2019. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

Bayesian Capital Management reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
Bayesian Capital Management sold 8,986 NEVRO CORP. shares in Q1 2023, an estimated $356K.
Bayesian Capital Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 5 quarters.
Bayesian Capital Management's NEVRO CORP. position peaked at $1.36M in Q4 2019.
158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.